Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Current Taxes: 2021-2022

  • Cartesian Therapeutics' Current Taxes was N/A to $320,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $320,000, marking a year-over-year change of. This contributed to the annual value of $601,000 for FY2021, which is N/A change from last year.
  • According to the latest figures from Q2 2022, Cartesian Therapeutics' Current Taxes is $320,000, which was down 0.00% from $320,000 recorded in Q1 2022.
  • Cartesian Therapeutics' 5-year Current Taxes high stood at $15.8 million for Q3 2021, and its period low was $320,000 during Q1 2022.
  • Moreover, its 2-year median value for Current Taxes was $460,500 (2021), whereas its average is $4.3 million.